Carlos Artigas Guix

Service(s) : Médecine nucléaire

carlos.artigas [at] hubruxelles.be

Publications

The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma.

Auteurs : Rodríguez-Fraile M, Tamayo Alonso P, Rosales JJ, de Arcocha-Torres M, Caresia-Aróztegui AP, Cózar-Santiago MP, Orcajo-Rincon J, Simó Perdigó M, Delgado Bolton RC, Artigas C
Année : 2022
Journal : Rev Esp Med Nucl Imagen Mol (Engl Ed)

(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Auteurs : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Année : 2022
Journal : J Nucl Med

Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence.

Auteurs : Bianchi L, Castellucci P, Farolfi A, Droghetti M, Artigas C, Leite J, Corona P, Shagera QA, Moreira R, González C, Queiroz M, de Galiza Barbosa F, Schiavina R, Deandreis D, Fanti S, Ceci F
Année : 2021
Journal : Eur Urol Oncol

Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series.

Auteurs : Farolfi A, Telo S, Castellucci P, Morais de Campos AL, Rosado-de-Castro PH, Altino de Almeida S, Artigas C, Scarlattei M, Leal A, Deandreis D, Fanti S, Fendler WP, Mosconi C, Pianori D, Ruffini L, Ceci F
Année : 2021
Journal : Am J Nucl Med Mol Imaging

Targeted radionuclide therapy: an emerging field in solid tumours.

Auteurs : Artigas C, Mileva M, Flamen P, Karfis I
Année : 2021
Journal : Curr Opin Oncol

Plus de publications »

Carlos Artigas Guix

Languages

Contact